The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicines and legal actions taken by regulatory authorities across the world. It also provides signals based on information derived from Individual Case Safety Reports (ICSRs) available in the WHO Global ICSR database, VigiBase®.

This newsletter includes three feature articles describing: Introduction of an electronic system for reporting adverse drug reactions in Tanzania, Third WHO Asia Pacific Pharmacovigilance Training Course, and Recommendations from the 39th Annual Meeting of Representatives of the National Pharmacovigilance Centres participating in the WHO Programme for International Drug Monitoring.

Posted on the WHO website on February 2017